Cargando…

A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants

Detalles Bibliográficos
Autores principales:	Zheng, Anqi, Wu, Lili, Ma, Renyi, Han, Pu, Huang, Baoying, Qiao, Chengpeng, Wang, Qihui, Tan, Wenjie, Gao, George F., Han, Pengcheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748180/ https://www.ncbi.nlm.nih.gov/pubmed/35013100 http://dx.doi.org/10.1038/s41392-021-00821-y

Ejemplares similares

Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2
por: Tang, Lingfeng, et al.
Publicado: (2022)

Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin
por: Niu, Sheng, et al.
Publicado: (2021)

Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
por: Liu, Kefang, et al.
Publicado: (2021)

Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
por: Su, Chao, et al.
Publicado: (2022)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s
por: Li, Linjie, et al.
Publicado: (2022)

Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses
por: Xu, Zepeng, et al.
Publicado: (2022)

Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
por: Han, Pengcheng, et al.
Publicado: (2021)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
por: Wang, Qihui, et al.
Publicado: (2020)

Host range and structural analysis of bat‐origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs
por: Hu, Yu, et al.
Publicado: (2023)

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
por: Liu, Juan, et al.
Publicado: (2023)

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
por: Wu, Yan, et al.
Publicado: (2020)

Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals
por: Li, Shihua, et al.
Publicado: (2022)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zhang, Zengyuan, et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
por: Du, Yanyun, et al.
Publicado: (2021)

Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants
por: Zhao, Xin, et al.
Publicado: (2021)

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3
por: Huang, Min, et al.
Publicado: (2022)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Huang, Qingrui, et al.
Publicado: (2021)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Huang, Qingrui, et al.
Publicado: (2021)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
por: Lee, Jong-Hwan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
por: López-Cortés, Georgina I., et al.
Publicado: (2021)

Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
por: Bracken, Colton J., et al.
Publicado: (2020)

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
por: Low, Jun Siong, et al.
Publicado: (2022)

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
por: Han, Pengcheng, et al.
Publicado: (2022)

Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach
por: Shafiq, Athar, et al.
Publicado: (2022)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
por: Duan, Xiaomin, et al.
Publicado: (2022)

Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
por: Wang, Yifan, et al.
Publicado: (2022)

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
por: Chaouat, Abigael E., et al.
Publicado: (2022)

An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant
por: Zhang, Haoran, et al.
Publicado: (2022)

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells
por: Kegler, Alexandra, et al.
Publicado: (2023)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
por: Astrakhantseva, Irina V., et al.
Publicado: (2023)

Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor
por: Miotto, Mattia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6b7gf1ov239ker76lh1d01tins